vimarsana.com

Latest Breaking News On - Endo international plc - Page 14 : vimarsana.com

The Global Generic drugs Market is expected to grow by

Global Generic Drugs Market 2023-2027 The analyst has been monitoring the generic drugs market and it is poised to grow by $176. 25 bn during 2023-2027,.

New yorkUnited statesEli lillyEndo international plcCipla ltdAurobindo pharma ltdGlaxosmithkline plcSun pharmaceutical industries ltdCadila pharmaceuticals ltdDr reddys laboratories ltdBaxter international incTeva pharmaceutical industries ltdPfizer incBiocon ltdAmgen incLupin ltd

Novartis To Pay $245 Mln To Settle Lawsuits Over Exforge Generics

BASEL (dpa-AFX) - Swiss drugmaker Novartis AG agreed to pay $245 million to settle an antitrust litigation for allegedly attempting to delay the launch of generic versions of its Exforge blood-pressure

United statesEndo international plc parRite aid corpKroger coMore such health newsWalgreens boots alliance incHealth corpEndo international plcPar pharmaceuticalRite aid

Peripheral neuropathy treatment market size to increase by USD 372 56 million: North America to contribute 33% of market growth

/PRNewswire/ The Peripheral Neuropathy Treatment Market by Type, Therapy and Geography - Forecast and Analysis 2023-2027 report has been published by.

United statesUnited kingdomGrunenthal gmbEli lillyJesse maidaEndo international plcCipla ltdTechnavio researchCadila pharmaceuticals ltdDr reddys laboratories ltdSun pharmaceutical industries ltdAstrazeneca plcTeva pharmaceutical industries ltdPfizer incApotex incDaiichi sankyo co

Female sexual dysfunction treatment market to grow by 32 7% Y-O-Y from 2022 to 2023: Increased awareness about female sexual dysfunction will drive growth

/PRNewswire/ Female sexual dysfunction treatment market insights - Vendors: 15+, Including Assos Ilac, Cipla Ltd., Dare Bioscience Inc., Dr Reddy s.

United statesUnited kingdomAssos ilacJesse maidaEndo international plcCipla ltdAge groupAge group segmentData table on age groupPharmbio korea incTechnavio researchDr reddy laboratories ltdTeva pharmaceutical industries ltdPalatin technologies incPfizer incDare bioscience inc

Endocrinology drugs market size to grow by USD 36551 24 Million: Increase in the incidence of endocrine disorders remains key growth driver

/PRNewswire/ The global endocrinology drugs market size is set to grow by USD 36551.24 million from 2022 to 2027, according to Technavio. The growth.

United statesUnited kingdomIpsen pharmaNovolog novorapidEli lillyJesse maidaEndo international plcOramed pharmaceuticals incGlaxosmithkline plcTechnavio researchMerck coPfizer incTakeda pharmaceutical coAcerus pharmaceuticals corpBiocon ltdF hoffmann la roche ltd

vimarsana © 2020. All Rights Reserved.